CureMatch’s co-founder and Chief Science Officer, Dr. Igor Tsigelny contributed to recently published cancer research concerning impact of viruses HTLV-1 and BLV on development of various cancers which could prove helpful to future CureMatch work. Findings are hopeful that it may be possible to eradicate these viruses acceleration of various cancers. The human T-cell leukemia […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.